In the context of thyroid cancer, EGCG inhibits the growth and increases apoptosis of human thyroid carcinoma cells through the suppression of the EGFR/RAS/RAF/MEK/ERK signaling pathway [63]. This evidence concerns the gene MAP2K7 and thyroid gland carcinoma.